Important Disclosure Information. Read Before Proceeding.
Companies
Chainalysis
Chainalysis
New York, NY
Founded 2014
Fintech
Chainalysis provides blockchain data and analysis to governments, banks, and businesses worldwide.
Last Round Valuation
$8.53B
Last Round Share Price
$ XX.XY
Total Funding
$587M
Last Round
Series F
Chainalysis
$9.03
1M
3M
YTD
1Y
2Y
MAX
Prices in chart are based on estimates only based on historical market data. These are not liquid investments.

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

News

Chainalysis Reports on Global Crypto Regulation Landscape thumbnail image
06/26/2025
Chainalysis Reports on Global Crypto Regulation Landscape
Chainalysis' report on global crypto regulation highlights the urgent need for compliance frameworks, influencing how businesses navigate risks and opportunities in an increasingly scrutinized digital asset landscape.
Chainalysis Reports Rising Security Risks in Stablecoins Amid Regulatory Concerns thumbnail image
06/18/2025
Chainalysis Reports Rising Security Risks in Stablecoins Amid Regulatory Concerns
The rising security risks in stablecoins highlight the urgent need for regulatory frameworks, as their instability could undermine investor confidence and disrupt the broader cryptocurrency market.
Nobitex Hacked for Over $90 Million in Politically Motivated Cyberattack thumbnail image
06/18/2025
Nobitex Hacked for Over $90 Million in Politically Motivated Cyberattack
The $90 million hack of Nobitex underscores the growing intersection of cybercrime and geopolitics, highlighting vulnerabilities in financial systems that could destabilize markets and erode trust in digital currencies.

Research

Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How can I get notified when there are new interested buyers of my shares?
Are orders posted anonymously?
How do Augment fees work?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.